1. Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial. Issue 9 (September 2022) Authors: Yamazaki, Tomoko; Gunderson, Andrew J; Gilchrist, Miranda; Whiteford, Mark; Kiely, Maria X; Hayman, Amanda; O'Brien, David; Ahmad, Rehan; Manchio, Jeffrey V; Fox, Nathaniel; McCarty, Kayla; Phillips, Michaela; Brosnan, Evelyn; Vaccaro, Gina; Li, Rui; Simon, Miklos; Bernstein, Eric; McCormick, Mar... Journal: Lancet oncology Issue: Volume 23:Issue 9(2022) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer. (4th November 2015) Authors: Curti, Brendan D; Akporiaye, Emmanuel; Sutcliffe, Kim; Bahjat, Keith S; Koguchi, Yoshinobu; Cramer, Julie; Urba, Walter Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer. Issue 2 (December 2015) Authors: Curti, Brendan; Akporiaye, Emmanuel; Sutcliffe, Kim; Bahjat, Keith; Koguchi, Yoshinobu; Cramer, Julie; Urba, Walter Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗